Key facts
- It has raised $39.5M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Qiming Venture Partners, Guolian Investment, Huatai Zijin Investment, Xiamen C&D Corporation, Chuchang Investment Group — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for LWBP
- ·The full record, as it builds
Funding rounds
No funding rounds for LWBP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LWBP
Developer of drugs designed to treat cancer. The company's drugs such as anti-infective and anti-viral drugs are used to cure cancer, enabling healthcare providers to make the lives of the patients better and healthier.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2012
- Employees
- 40
- Website
- lwbpsh.com/
- Ownership
- Privately Held (backing)
LWBP doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LWBP shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LWBP in its N-PORT filings yet. We sweep new filings monthly.